Sign in

Medtronic plc

MDT

Share price not shown yet: live market data is not connected. Everything below comes from MDT’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Rule of 40
26%
rev growth + FCF margin
Revenue growth
+9.8%
TTM vs prior TTM
FCF margin
16.3%
ROE (TTM)
0.9%
TTM NI ÷ avg equity
Net debt
$19.3B
total debt − cash & ST inv.
Dilution (YoY)
-0.3%
negative = buybacks
SBC / revenue
1.3%
TTM revenue
$37.5B

Revenue

$0B$2B$4B$6B$8B$10BJan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’26$10B

EPS (diluted)

$0.00$0.20$0.40$0.60$0.80$1.00$1.20Jan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’26$1.14

Operating

12%14%16%18%20%22%Jan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’2618%

Net income

-$4B-$3B-$2B-$1B$0B$1BJan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’26$1B

Net margin

-40%-20%0%20%Jan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’2615%

Free cash flow vs. stock-based comp

FCFSBC
$0.0B$0.5B$1.0B$1.5B$2.0B$2.5BJan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’26$1.3B

Operating cash flow vs. capex

OCFCapex
$0.0B$0.5B$1.0B$1.5B$2.0B$2.5BJan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’26$1.8B

R&D vs. SG&A

R&DSG&A
$0B$1B$2B$3BJan ’22Oct ’22Jul ’23Apr ’24Jan ’25Oct ’25Jul ’26$1B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…